A single-institution experience of pneumonitis in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.

被引：0
|
作者：
Masur, Jack
Ali, Soham
Fortune, Kathryn
Bueno, Juliana
Battey, Thomas
Mullapudi, Abhishek
Goudarzi, Ariaz
Patel, Hitesh
Sturek, Jeffrey
Devitt, Michael Edward
Skelton, William Paul
Dreicer, Robert
Viscuse, Paul Vincent
机构：
[1] Univ Virginia, Div Hematol Oncol, Charlottesville, VA USA
[2] Univ Virginia, Dept Internal Med, Charlottesville, VA USA
[3] Univ Virginia, Dept Radiol & Med Imaging, Charlottesville, VA USA
[4] Univ Virginia, Sch Med, Charlottesville, VA USA
[5] Univ Virginia, Div Pulm & Crit Care Med, Charlottesville, VA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2025年 / 43卷 / 5_SUPPL期
关键词：
D O I：
10.1200/JCO.2025.43.5_suppl.475
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Impact of antibiotics on outcome in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors.
    Derosa, Lisa
    Routy, Bertrand
    Enot, David
    Baciarello, Giulia
    Massard, Christophe
    Loriot, Yohann
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [2] A single-institution study of renal outcomes in patients receiving checkpoint inhibitors.
    Mushtaq, Sarah
    Kerr, Daniel Alan
    Mirza, Abu-Sayeef
    Shah, Bijal D.
    Bassil, Claude
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Angiosarcoma treated with checkpoint inhibitors: A single-institution experience.
    Florou, Vaia
    Wilky, Breelyn A.
    Trent, Jonathan C.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [4] Efficacy of immune checkpoint inhibitors in advanced large cell neuroendocrine carcinoma of the lung: A single-institution experience
    Yan, Ningning
    Guo, Sanxing
    Zhang, Ziheng
    Shen, Shujing
    Li, Xingya
    ONCOLOGY LETTERS, 2024, 27 (03)
  • [5] Metastatic sarcomatoid renal cell carcinoma treated with immune checkpoint inhibitors
    Hanif, Ahmad
    Pandey, Manu
    Khan, Sumera
    Attwood, Kristopher
    George, Saby
    ONCOIMMUNOLOGY, 2019, 8 (08):
  • [6] Outcomes of patients with late relapse metastatic renal cell carcinoma treated with targeted therapies: A single-institution experience.
    Mandalapu, Kemal Kishore
    Matrana, Marc Ryan
    Poosarla, Teja
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [7] The Role of Surgery in Renal Cell Carcinoma Metastatic to the Pancreas: a Single-Institution Experience
    Morandi, E.
    Castoldi, M.
    Merlini, D. A.
    Turati, L.
    Milanesi, M.
    PANCREAS, 2012, 41 (08) : 1387 - 1387
  • [8] Efficacy and Safety of Sunitinib on Metastatic Renal Cell Carcinoma: A Single-Institution Experience
    Hwang, Eugene
    Lee, Hyo Jin
    Sul, Chong Koo
    Lim, Jae Sung
    KOREAN JOURNAL OF UROLOGY, 2010, 51 (07) : 450 - 455
  • [9] Potential role of hypovitaminosis D in renal cell carcinoma patients treated with immune-checkpoint inhibitors.
    Bersanelli, Melissa
    Vaglio, Augusto
    Sverzellati, Nicola
    Galetti, Maricla
    Incerti, Monia
    Parziale, Raffaele
    Corrado, Michele
    Cosenza, Agnese
    Ferri, Leonarda
    Leonardi, Francesco
    Buti, Sebastiano
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [10] Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
    Lee, Ji Hyun
    Hwang, Soohyun
    Jee, ByulA
    Kim, Jae-Hun
    Lee, Jihwan
    Chung, Jae Hoon
    Song, Wan
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byong Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Park, Se Hoon
    Kwon, Ghee Young
    Kang, Minyong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (04)
12345